Gene Expression Regulation, Neoplastic
"Gene Expression Regulation, Neoplastic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue.
| Descriptor ID |
D015972
|
| MeSH Number(s) |
G05.308.370
|
| Concept/Terms |
Gene Expression Regulation, Neoplastic- Gene Expression Regulation, Neoplastic
- Regulation of Gene Expression, Neoplastic
- Regulation, Gene Expression, Neoplastic
- Neoplastic Gene Expression Regulation
|
Below are MeSH descriptors whose meaning is more general than "Gene Expression Regulation, Neoplastic".
Below are MeSH descriptors whose meaning is more specific than "Gene Expression Regulation, Neoplastic".
This graph shows the total number of publications written about "Gene Expression Regulation, Neoplastic" by people in this website by year, and whether "Gene Expression Regulation, Neoplastic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 1 | 2 |
| 2004 | 2 | 4 | 6 |
| 2005 | 1 | 4 | 5 |
| 2006 | 3 | 0 | 3 |
| 2007 | 0 | 3 | 3 |
| 2008 | 4 | 1 | 5 |
| 2009 | 1 | 3 | 4 |
| 2010 | 2 | 4 | 6 |
| 2011 | 1 | 2 | 3 |
| 2012 | 2 | 4 | 6 |
| 2013 | 2 | 4 | 6 |
| 2014 | 5 | 6 | 11 |
| 2015 | 3 | 4 | 7 |
| 2016 | 6 | 10 | 16 |
| 2017 | 98 | 222 | 320 |
| 2018 | 86 | 183 | 269 |
| 2019 | 30 | 68 | 98 |
| 2020 | 2 | 3 | 5 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Gene Expression Regulation, Neoplastic" by people in Profiles.
-
Clinical significance and molecular mechanism of angiotensin-converting enzyme 2 in hepatocellular carcinoma tissues. Bioengineered. 2021 12; 12(1):4054-4069.
-
Prognostic and immunological value of ATP6AP1 in breast cancer: implications for SARS-CoV-2. Aging (Albany NY). 2021 07 06; 13(13):16904-16921.
-
Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung Tissues. Curr Cancer Drug Targets. 2021 07 05; 21(5):428-442.
-
In silico analysis identifies neuropilin-1 as a potential therapeutic target for SARS-Cov-2 infected lung cancer patients. Aging (Albany NY). 2021 06 24; 13(12):15770-15784.
-
The role of mediator complex subunit 19 in human diseases. Exp Biol Med (Maywood). 2021 08; 246(15):1681-1687.
-
Downregulation of ACE2 expression by SARS-CoV-2 worsens the prognosis of KIRC and KIRP patients via metabolism and immunoregulation. Int J Biol Sci. 2021; 17(8):1925-1939.
-
African Americans and European Americans exhibit distinct gene expression patterns across tissues and tumors associated with immunologic functions and environmental exposures. Sci Rep. 2021 05 10; 11(1):9905.
-
Network controllability-based algorithm to target personalized driver genes for discovering combinatorial drugs of individual patients. Nucleic Acids Res. 2021 04 19; 49(7):e37.
-
Cockayne Syndrome Group B (CSB): The Regulatory Framework Governing the Multifunctional Protein and Its Plausible Role in Cancer. Cells. 2021 04 10; 10(4).
-
ACE2 correlates with immune infiltrates in colon adenocarcinoma: Implication for COVID-19. Int Immunopharmacol. 2021 Jun; 95:107568.